Page 21 - KELAG Annual Report 2017

Amendments: Sale or
IAS 28 contribution of assets Postponed
IFRS 10 between an investor and its 11/9/2014 (deferred) indefinitely See below
associate or joint venture
Amendments: Investment 8/12/2016
IAS 40 1/1/2018 None
property (expected for Q1/2018)
Foreign Currency 8/12/2016
IFRIC 22 Transactions and Advance 1/1/2018 See below
Consideration (expected for Q1/2018)
Uncertainty over Income Tax 7/6/2017
IFRIC 23 1/1/2019 See below
Treatments (expected for Q3 2018)
Amendments: Prepayment 12/10/2017
IFRS 9 Features with Negative 1/1/2019 None
Compensation (expected for Q1 2018)
Amendments: Long-term 12/10/2017
IAS 28 Interests in Associates and 1/1/2019 See below
Joint Ventures (expected for 2018)
30/1/2014
IFRS 14 Regulatory Deferral Accounts - None
(no adoption planned)
Annual Improvements to 12/12/2017
Various 1/1/2019 None
IFRSs (2015 to 2017 cycle) (expected for 2018)
IFRS 17 Insurance Contracts 18/5/2017 1/1/2021 None

The planned amendments to IAS 28 and IFRS 10 require that, in future, the entire profit or loss be
recorded if the assets sold or contributed qualify as a business operation within the meaning of
IFRS 3; any such transactions concluded in the future can have an impact.

IFRIC 22 clarifies the accounting treatment of transactions that contain considerations received or
paid in foreign currency by addressing the question of when the exchange rate should be
determined to translate foreign currency transactions. This interpretation is to be applied from
financial year 2018. The KELAG Group does not anticipate any significant effects.

IFRIC 23 clarified which uncertainties are to be recognised for (future) income taxes e.g., if the tax
treatment depends on the future approval of financial authorities or the system of finance courts.
The Group does not anticipate any significant effect from the planned endorsement of this
interpretation, which is scheduled for 2018.